Related Experiment Video
Updated: Jun 11, 2025

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
The Interaction of Complement and Intrinsic Coagulation System: A Comparative Study between COVID-19 and Bacterial
Dimitrios-Dorotheos Papadakis1, Marianna Politou2, Theodoros Pittaras2
1Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 115 27 Athens, Greece.
Complement activation is more pronounced in COVID-19 patients than in bacterial sepsis, suggesting distinct pathways. Coagulation factors showed no significant differences between the two severe infections.
Area of Science:
- Immunology
- Hematology
- Infectious Diseases
Background:
- The complement and coagulation cascades are known to interact.
- Both severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and bacterial sepsis strongly activate these cascades.
- Understanding their interplay is crucial for managing critical illnesses.
Purpose of the Study:
- To compare complement and intrinsic coagulation pathway activation in patients with COVID-19 versus bacterial sepsis.
- To investigate the interplay between these two systems in the context of these infections.
Main Methods:
- Serum and plasma samples were collected from 25 ICU patients (11 COVID-19, 14 bacterial sepsis) at admission and during follow-up.
- Activities of coagulation factors XI and XII were measured.
- Levels of complement factors C3a and C5a were quantified.
Main Results:
- Coagulation factors XI and XII activities were elevated in both groups but showed no significant inter-group differences.
- Complement factors C3a and C5a were significantly higher in COVID-19 patients upon admission and during follow-up.
- These findings suggest a more pronounced complement activation in COVID-19.
Conclusions:
- Complement activation appears to be more significantly enhanced in COVID-19 compared to bacterial sepsis.
- The lack of significant differences in coagulation factors XI and XII suggests alternative pathways for complement activation in SARS-CoV-2 infection.
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...

